Related Experiment Video
Updated: Jun 23, 2026
08:56
Generating Self-Assembling Human Heart Organoids Derived from Pluripotent Stem Cells
Published on: September 15, 2021
Cardiovascular Organoids With Adjustable Endothelial Composition via SOX17-Engineered hPSCs
Po-Yu Liang1,2, Gyuhyung Jin1,2, Nathan R Petrucci3
1Davidson School of Chemical Engineering, Purdue University, West Lafayette, Indiana, USA.
Biotechnology and Bioengineering
|June 21, 2026
Summary
Researchers developed advanced cardiovascular organoids from genome-edited stem cells. These 3D models accurately replicate human heart conditions and drug responses, offering a new tool for heart disease research.
Area of Science:
- Cardiovascular Research
- Stem Cell Biology
- Organoid Technology
Background:
- Organoids represent a novel platform for human biology and health research.
- Organoids enable the study of complex 3D structures and multicellular interactions.
- Cardiovascular organoids offer a reliable model for studying heart conditions.
Purpose of the Study:
- To generate an advanced cardiovascular organoid using a genome-edited human pluripotent stem cell line.
- To achieve controlled endothelial specification, adjustable cell-type composition, and human heart-like morphology.
- To establish a robust and easy-to-produce platform for studying human heart disease.
Main Methods:
- Utilized a genome-edited human pluripotent stem cell line with inducible SOX17 expression.
- Generated 3D cardiovascular organoids with controllable cellular composition and heart-like structures.
- Tested organoid response to doxorubicin, cryoinjury-induced myocardial infarction, and isoproterenol.
Main Results:
- Organoids recapitulated cardiotoxic effects of doxorubicin, showing decreased viability and contractile activity.
- Myocardial infarction model showed reduced beating, viability, and α-actinin expression, with increased fibroblast formation, mitigated by Captopril.
- Isoproterenol treatment demonstrated effects on Ca2+ transient amplitude and action potential duration, consistent with β-adrenergic responses.
Conclusions:
- Established a protocol for generating in vitro 3D cardiovascular organoids.
- Developed a controllable and reproducible platform for cardiovascular research.
- The cardiovascular organoid model provides a robust tool for future studies of human heart disease.
